Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2 mediated SARS-CoV-2 entry

被引:24
作者
Ragia, Georgia [1 ]
Manolopoulos, Vangelis G. [1 ,2 ]
机构
[1] Democritus Univ Thrace, Med Sch, Lab Pharmacol, Alexandroupolis 68100, Greece
[2] Acad Gen Hosp Alexandroupolis, Clin Pharmacol & Pharmacogenet Unit, Alexandroupolis 68100, Greece
关键词
(epi)genetics; ACE2; ADAM-17; COVID-19; FURIN; genetic classifier; SARS-CoV-2; TMPRSS2; ANGIOTENSIN-CONVERTING ENZYME; ANDROGEN RECEPTOR; DNA METHYLATION; ESTROGEN; POLYMORPHISMS; EXPRESSION; ASSOCIATION; TISSUE; TMPRSS2; CANCER;
D O I
10.2217/pgs-2020-0092
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There is considerable variation in disease course among individuals infected with SARS-CoV-2. Many of them do not exhibit any symptoms, while some others proceed to develop COVID-19; however, severity of COVID-19 symptoms greatly differs among individuals. Focusing on the early events related to SARS-CoV-2 entry to cells through the ACE2 pathway, we describe how variability in (epi)genetic factors can conceivably explain variability in disease course. We specifically focus on variations in ACE2, TMPRSS2 and FURIN genes, as central components for SARS-CoV-2 infection, and on other molecules that modulate their expression such as CALM, ADAM-17, AR and ESRs. We propose a genetic classifier for predicting SARS-CoV-2 infectivity potential as a preliminary tool for identifying the at-risk-population. This tool can serve as a dynamic scaffold being updated and adapted to validated (epi)genetic data. Overall, the proposed approach holds potential for better personalization of COVID-19 handling.
引用
收藏
页码:1311 / 1329
页数:19
相关论文
共 93 条
[1]   The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans [J].
Ardlie, Kristin G. ;
DeLuca, David S. ;
Segre, Ayellet V. ;
Sullivan, Timothy J. ;
Young, Taylor R. ;
Gelfand, Ellen T. ;
Trowbridge, Casandra A. ;
Maller, Julian B. ;
Tukiainen, Taru ;
Lek, Monkol ;
Ward, Lucas D. ;
Kheradpour, Pouya ;
Iriarte, Benjamin ;
Meng, Yan ;
Palmer, Cameron D. ;
Esko, Tonu ;
Winckler, Wendy ;
Hirschhorn, Joel N. ;
Kellis, Manolis ;
MacArthur, Daniel G. ;
Getz, Gad ;
Shabalin, Andrey A. ;
Li, Gen ;
Zhou, Yi-Hui ;
Nobel, Andrew B. ;
Rusyn, Ivan ;
Wright, Fred A. ;
Lappalainen, Tuuli ;
Ferreira, Pedro G. ;
Ongen, Halit ;
Rivas, Manuel A. ;
Battle, Alexis ;
Mostafavi, Sara ;
Monlong, Jean ;
Sammeth, Michael ;
Mele, Marta ;
Reverter, Ferran ;
Goldmann, Jakob M. ;
Koller, Daphne ;
Guigo, Roderic ;
McCarthy, Mark I. ;
Dermitzakis, Emmanouil T. ;
Gamazon, Eric R. ;
Im, Hae Kyung ;
Konkashbaev, Anuar ;
Nicolae, Dan L. ;
Cox, Nancy J. ;
Flutre, Timothee ;
Wen, Xiaoquan ;
Stephens, Matthew .
SCIENCE, 2015, 348 (6235) :648-660
[2]   Expression of ERG protein in prostate cancer: variability and biological correlates [J].
Ayala, Gustavo ;
Frolov, Anna ;
Chatterjee, Deyali ;
He, Dandan ;
Hilsenbeck, Susan ;
Ittmann, Michael .
ENDOCRINE-RELATED CANCER, 2015, 22 (03) :277-287
[3]   ACE2gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population [J].
Benetti, Elisa ;
Tita, Rossella ;
Spiga, Ottavia ;
Ciolfi, Andrea ;
Birolo, Giovanni ;
Bruselles, Alessandro ;
Doddato, Gabriella ;
Giliberti, Annarita ;
Marconi, Caterina ;
Musacchia, Francesco ;
Pippucci, Tommaso ;
Torella, Annalaura ;
Trezza, Alfonso ;
Valentino, Floriana ;
Baldassarri, Margherita ;
Brusco, Alfredo ;
Asselta, Rosanna ;
Bruttini, Mirella ;
Furini, Simone ;
Seri, Marco ;
Nigro, Vincenzo ;
Matullo, Giuseppe ;
Tartaglia, Marco ;
Mari, Francesca ;
Renieri, Alessandra ;
Pinto, Anna Maria .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (11) :1602-1614
[4]   Status of TMPRSS2-ERG fusion in prostate cancer patients from India: correlation with clinico-pathological details and TMPRSS2 Met160Val polymorphism [J].
Bhanushali, Aparna ;
Rao, Pranesh ;
Raman, Vaishnavi ;
Kokate, Prajakta ;
Ambekar, Asawari ;
Mandva, Swarna ;
Bhatia, Simi ;
Das, B. R. .
PROSTATE INTERNATIONAL, 2018, 6 (04) :145-150
[5]   Furin-mediated protein processing in infectious diseases and cancer [J].
Braun, Elisabeth ;
Sauter, Daniel .
CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2019, 8 (08)
[6]   Tissue-specific regulation of ACE/ACE2 and AT1/AT2 receptor gene expression by oestrogen in apolipoprotein E/oestrogen receptor-α knock-out mice [J].
Brosnihan, K. Bridget ;
Hodgin, Jeffrey B. ;
Smithies, Oliver ;
Maeda, Nobuyo ;
Gallagher, Patricia .
EXPERIMENTAL PHYSIOLOGY, 2008, 93 (05) :658-664
[7]   Protective regulation of the ACE2/ACE gene expression by estrogen in human atrial tissue from elderly men [J].
Bukowska, A. ;
Spiller, L. ;
Wolke, C. ;
Lendeckel, U. ;
Weinert, S. ;
Hoffmann, J. ;
Bornfleth, P. ;
Kutschka, I. ;
Gardemann, A. ;
Isermann, B. ;
Goette, A. .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2017, 242 (14) :1412-1423
[8]   The ACE2 gene: its potential as a functional candidate for cardiovascular disease [J].
Burrell, Louise M. ;
Harrap, Stephen B. ;
Velkoska, Elena ;
Patel, Sheila K. .
CLINICAL SCIENCE, 2013, 124 (1-2) :65-76
[9]   Calmodulin Mutations Associated with Heart Arrhythmia: A Status Report [J].
Chazin, Walter J. ;
Johnson, Christopher N. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (04)
[10]   Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation [J].
Chen, Jiawei ;
Jiang, Quanlong ;
Xia, Xian ;
Liu, Kangping ;
Yu, Zhengqing ;
Tao, Wanyu ;
Gong, Wenxuan ;
Han, Jing-Dong J. .
AGING CELL, 2020, 19 (07)